Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

InflaRx completes enrolment in hidradenitis suppurativa trial

InflaRx is developing new anti-C5a medicines for inflammatory diseases. Credit: e-Magine Art.

  • InflaRx new drug trial

Go Top